Biopharma News

Scientists have discovered that TR4 plays an integral role in Cushing's disease

Marijuana use has been associated with lower fasting insulin levels

Improved understanding of the formulation of biofilm could pave the way for new treatments

Cobra Biologics and biotechnology firm Vaccibody AS announce new partnership

An NDA has been submitted for a new pneumonia antibiotic being developed in Taiwan

A biopharmaceutical group has unveiled funding for LSD therapies research

Researchers appear to have uncovered a genetic risk factor for pulmonary fibrosis

The drug may target LRRK2 and JNK enzymes in order to reduce Parkinson's symptoms and slow disease progression.

Dr Raymond Woosley will join the board of directors at ARCA biopharma.

An NDA has been submitted for a new treatment targeting hypertension

Research has revealed 64 per cent of children have been readmitted to hospital after stem cell transplants.

Researchers have reported that benzophenone, which is found in African plants, could prevent tumours from growing.

Researchers are looking at a new treatment for reducing the amount of times a person needs to take insulin for type 1 diabtes.

The company is aiming develop and commercialise innovative new therapies in dermatology.

Researchers have developed a possible vaccine for heroin addiction

Scientists are learning more about how drugs work , which could lead to better, more effective versions.

Research has suggested EPA is associated with skin graft failure

Researchers have made a breakthrough on why some dengue virus patients develop complications

Potential targets have been identified for pharmacological efforts to address obesity

Pre-clinical data on TG1050 was presented at EASL 2013, which took place in Amsterdam

A study has shown chemoresponse assays could be effective for improving ovarian cancer survival rates.

Merck is celebrating after its new melanoma treatment was given Breakout Therapy status by the FDA

Microwave imaging may be a useful way to monitor the effectiveness of breast cancer treatment.

A pain treatment is one step closer to targeting the rare disease erythromelalgia.

A diagnostic kit for rheumatoid arthritis has been given a CE Mark.

A project is in the pipeline to grow a complex 3D tumour microenvironment in vitro.

The debut implantation of a resorbable antibacterial envelope has been revealed.

Research finds effectiveness of smallpox vaccine is down to genes.

A team of scientists are closer to developing an anti-obesity drug

Median Technologies has been awarded a phase II clinical trial on non-small lung cancer

Research has shown how radiation dose can affect size of lung nodules observed on CT images.

A survey has shed light on some physcicians' attitudes to pharmaceutical companies.

A report has suggested FDA review periods for biomarker-based IVD tests are getting longer.

Technology is being developed to predict the effectiveness of radiation therapy.

An antibiotic drug has been found to be beneficial for children with fragile X.